W Scott Butsch
10PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Oct 03, 2025
Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice.Hamlet Gasoyan, W Scott Butsch, Nicholas J Casacchia
|Jun 10, 2025
Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status.Hamlet Gasoyan, W Scott Butsch, Rebecca Schulte
|Jun 10, 2024
Nutritional considerations with antiobesity medications.Jaime P Almandoz, Thomas A Wadden, Colleen Tewksbury
|Sep 28, 2023
Obesity preclinical elective: a qualitative thematic analysis of student feedback.Amber Olson, Katherine Lyons, Rosanna Watowicz
|Aug 07, 2023
Health state utilities associated with hyperphagia: Data for use in cost-utility models.Timothy A Howell, Louis S Matza, Usha G Mallya
|Sep 26, 2022
The use of virtual visits for obesity pharmacotherapy in patients with overweight or obesity compared with in-person encounters.Marcio L Griebeler, W Scott Butsch, Paloma Rodriguez
Pageof 2
Frequent Collaborators
3 joint publications
Jesse Richards
3 joint publications
Lisa M Neff
3 joint publications
Kadie S Vanderman
3 joint publications
Zhaoping Li
3 joint publications
Jamy D Ard
3 joint publications
Caroline M Apovian
3 joint publications
Jaime P Almandoz
3 joint publications
Thomas A Wadden
2 joint publications
Fatima Cody Stanford
2 joint publications
Bartolome Burguera
